Watch: Latest ‘Champions of Science’ Videos Unveiled at BIO

Watch: Latest ‘Champions of Science’ Videos Unveiled at BIO


“What if?”

These magic words have inspired scientists for hundreds of years and continue to drive innovation today — in healthcare and beyond. From novel antibiotics to personalized vaccines, scientists are creating new solutions that aim to improve the human condition and enable longer, healthier lives.

But too often, the fascinating science behind these important research projects are complex for non-specialists to understand. Human health isn’t always easy to explain. But everyone deserves to understand the science of healthcare.

With the goal of removing this mystery to convey the breakthrough science behind our collaborations, J&J Innovation has launched an ongoing series of ‘Champions of Science’ videos. Each video explores, in an accessible way, what could happen if we took a new approach to one of society’s biggest healthcare challenges.

We’re unveiling the latest of these videos in advance of the life science industry’s global meeting — the BIO International Convention — held June 4-7 in Boston. By showcasing some of the innovations we are working on with our collaborators at this major biopharma gathering, we hope to inspire others to similarly share their science in a way that will resonate with the world and join us in showcasing the importance of collaboration to drive innovation.

Check out the latest videos below. And if you like what you see, be sure to follow us on Twitter @JNJInnovation. We’ll be championing science at BIO and beyond.


Changes in our gut’s microbiome are potentially associated with cancer, inflammatory bowel disease and even mental health disorders. What if we could identify the bacteria associated with these diseases?


Our first 1,000 days leave life-long impressions. What if we could precisely measure how these experiences affect newborns’ cognitive development?


Antibodies are incredible molecular detectives, finding and binding intruders with exquisite specificity. But what if we created an antibody that binds multiple targets?